Record revenue of $750 million, up 38% year-over-year Record Non-GAAP net earnings of $168 million, up 88% year-over-year, and GAAP net income of $147 million, up 99% year-over-year Record operating cash flow of $165 million, up 19% year-over-year, and record free cash flow of $149 million, up 26% Read more
MENLO PARK, Calif., July 28, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted restricted stock units (“RSUs”) covering 29,500 shares of Pacific Biosciences common stock, to a... Read more
Mailing addressesCorrespondence should be mailed to:ComputershareP.O. Box 505000Louisville, KY 40233 Overnight correspondence should be sent to:Computershare462 South 4th Street, Suite 1600Louisville, KY 40202 Shareholder website www.computershare.com/investorShareholder online inquirieswww-us.computershare.com/investor/Contact Read more
WALTHAM, Mass., July 28, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended July 3, 2021. Second Quarter 2021 Highlights Second quarter revenue increased 34% to $9.27 billion. Second quarter GAAP diluted earnings per share (EPS) increased 59% to... Read more
July 27, 2021 at 6:30 AM EDTPDF Version Agreement to Cross License Single Cell Technologies Ends all Ongoing Legal Disputes PLEASANTON, Calif., July 27, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today announced that it has entered into a global settlement and cross-license agreement with Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb). The... Read more
ANDOVER, Mass., July 27, 2021 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.22 per share, payable on Read more
Accelerated efforts align with the Paris Agreement and Race To Zero to combat climate change WALTHAM, Mass., July 27, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced its commitment to achieve net-zero carbon emissions by 2050. This supports the global goals of the Paris Climate Agreement and... Read more
Researchers use widefield microscopy to image adipose and brain tissue as part of their work to find new ways to treat obesity. Obesity refers to the excessive amount of body fat, often as a result from eating more calories (energy) than are used. This can be a serious medical issue with increased risk of health... Read more
Revenue of $1.228 billion; 51% reported growth; 41% organic growth GAAP EPS from continuing operations of $2.19; Adjusted EPS of $2.83 Initiates Third Quarter and Raises Full-Year Revenue and Earnings Guidance Announces Agreement to Acquire BioLegend – Leading Antibody & Research Reagent Provider Earnings Call Moved to Today at 8:00 a.m. Eastern Time; Dial-in Information... Read more
Transformative deal significantly scales leading position in life science to accelerate legendary discoveries in precision medicine Leader in antibody development with highly complementary, innovative portfolio in emerging, high-growth areas of biologics, cell and gene therapy, proteogenomics, and recombinant proteins Commercial synergy opportunity to accelerate life science growth with potential benefits for diagnostics franchise Annual BioLegend... Read more